<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Presseportal.de - Takeda Pharmaceuticals Europe Ltd</title><link>http://www.presseportal.de/pm/67523/takeda-pharmaceuticals-europe-ltd/rss</link><description>Presseportal.de: Takeda Pharmaceuticals Europe Ltd (Digitale Pressemappe)</description><language>de-de</language><copyright>news aktuell GmbH</copyright><image><url>http://www.presseportal.de/images/logo_napresseportal.gif</url><title>Presseportal.de - Takeda Pharmaceuticals Europe Ltd</title><link>http://www.presseportal.de/pm/67523/takeda-pharmaceuticals-europe-ltd/rss</link></image><managingEditor>redaktion@presseportal.de (Jens Petersen)</managingEditor><pubDate>Sat, 11 Feb 2012 02:34:13 +0100</pubDate><lastBuildDate>Fri, 23 Sep 2011 14:29:44 +0200</lastBuildDate><category></category><ttl>6</ttl><item><title>Takeda Receives Positive CHMP Opinion in Europe for Edarbi(TM) (azilsartan medoxomil) for the Treatment of Essential Hypertension</title><description>Takeda Pharmaceuticals Europe Ltd: London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for ...</description><link>http://www.presseportal.de/pm/67523/2117944/takeda-receives-positive-chmp-opinion-in-europe-for-edarbi-tm-azilsartan-medoxomil-for-the/rss</link><pubDate>Fri, 23 Sep 2011 14:29:44 +0200</pubDate><guid>http://www.presseportal.de/pm/67523/2117944/takeda-receives-positive-chmp-opinion-in-europe-for-edarbi-tm-azilsartan-medoxomil-for-the/rss</guid>
<content:encoded><![CDATA[<b>Takeda Pharmaceuticals Europe Ltd</b> [<a href="http://www.presseportal.de/pm/67523/2117944/takeda-receives-positive-chmp-opinion-in-europe-for-edarbi-tm-azilsartan-medoxomil-for-the/rss">Pressemappe</a>]<br/>London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for ... <a href="http://www.presseportal.de/pm/67523/2117944/takeda-receives-positive-chmp-opinion-in-europe-for-edarbi-tm-azilsartan-medoxomil-for-the/rss">Lesen Sie hier weiter...</a><br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1" />
]]></content:encoded><category>Wirtschaft</category><author>redaktion@presseportal.de (Jens Petersen)</author><source url="http://www.presseportal.de/pm/67523/2117944/takeda-receives-positive-chmp-opinion-in-europe-for-edarbi-tm-azilsartan-medoxomil-for-the/rss">Excelitas Technologies</source></item><item><title>Takeda Responds to FDA Advisory Committee Recommendation</title><description>Takeda Pharmaceuticals Europe Ltd: London, July 15, 2010 (ots/PRNewswire) - The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing ...</description><link>http://www.presseportal.de/pm/67523/1648443/takeda-responds-to-fda-advisory-committee-recommendation/rss</link><pubDate>Thu, 15 Jul 2010 01:07:30 +0200</pubDate><guid>http://www.presseportal.de/pm/67523/1648443/takeda-responds-to-fda-advisory-committee-recommendation/rss</guid>
<content:encoded><![CDATA[<b>Takeda Pharmaceuticals Europe Ltd</b> [<a href="http://www.presseportal.de/pm/67523/1648443/takeda-responds-to-fda-advisory-committee-recommendation/rss">Pressemappe</a>]<br/>London, July 15, 2010 (ots/PRNewswire) - The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing ... <a href="http://www.presseportal.de/pm/67523/1648443/takeda-responds-to-fda-advisory-committee-recommendation/rss">Lesen Sie hier weiter...</a><br clear="all" /><IMG SRC="http://presspor.ivwbox.de/cgi-bin/ivw/CP/de_1003" WIDTH="1" HEIGHT="1" />
]]></content:encoded><category>Wirtschaft</category><author>redaktion@presseportal.de (Jens Petersen)</author><source url="http://www.presseportal.de/pm/67523/1648443/takeda-responds-to-fda-advisory-committee-recommendation/rss">Excelitas Technologies</source></item></channel></rss>
